Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CalliSpheres microsphere chemoembolization for refractory intrahepatic cholangiocarcinoma
ChiCTR2200058101Phase 4Not yet recruiting
- Sponsor
- Shanghai International Medical Center
- Start
- Apr 2022
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of polyvinyl alcohol in intrahepatic cholangiocarcinoma (ICC), sponsored by Shanghai International Medical Center. Primary endpoint: Objective response rate (ORR). Planned start Apr 2022; status: not yet recruiting.
02
Drugs
polyvinyl alcohol
03
Conditions
intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on ChiCTR2200058101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058101.